![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Alzheimer's Disease |
|
Free Subscription
1 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
A new era of genome-wide association studies in the field of Alzheimer's disease
and overlapping co-pathologies: lessons learned from a neuropathology-centered
approach.
Acta Neuropathol. 2026;152:35.
PubMed
Abstract available
Operationalizing Alzheimer's disease trials in the era of targeted therapies.
Alzheimers Dement. 2026;22:e71829.
PubMed
Abstract available
Rethinking tau-targeted therapy in Alzheimer's disease: Toward a dual biomarker
strategy.
Alzheimers Dement. 2026;22:e71867.
PubMed
Abstract available
Genetic and molecular evidence linking CTSH to Alzheimer's disease
pathophysiology.
Alzheimers Dement. 2026;22:e71833.
PubMed
Abstract available
Digital cognitive phenotyping enhances risk stratification in preclinical
Alzheimer's disease.
Alzheimers Dement. 2026;22:e71834.
PubMed
Abstract available
Incidence and risk factors for AD/ADRD among American Indian and Alaska Native US
Veterans.
Alzheimers Dement. 2026;22:e71856.
PubMed
Abstract available
Associations between serum estradiol and estrone and Alzheimer's disease
biomarkers: An analysis in female participants from the European Prevention of
Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS).
Alzheimers Dement. 2026;22:e71826.
PubMed
Abstract available
Am J Alzheimers Dis Other Demen
Global Postural Reeducation in Mild Alzheimer's Disease: A Secondary Analysis of
an RCT.
Am J Alzheimers Dis Other Demen. 2026;41:15333175261489372.
PubMed
Abstract available
Alzheimer's Co-Pathology Burden on Basal Forebrain Atrophy and Cognitive
Impairment in Dementia with Lewy Bodies: A Cross-Sectional Pilot Study.
Ann Neurol. 2026 Sep 16. doi: 10.1002/ana.78357.
PubMed
Abstract available
Distribution of Big Tau Isoforms in the Human Central and Peripheral Nervous
System.
Ann Neurol. 2026;100:709-736.
PubMed
Abstract available
Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker
Progression.
Ann Neurol. 2026;100:695-708.
PubMed
Abstract available
Alzheimer's disease-associated transcriptional signatures define prognostic
subtypes in glioma.
Brain Res. 2026 Sep 18:150525. doi: 10.1016/j.brainres.2026.150525.
PubMed
Abstract available
Integrated proteomics and network pharmacology reveal autophagy-lysosomal
regulation underlying sulforaphane-mediated neuroprotection in Alzheimer's
disease.
Brain Res. 2026 Sep 14:150549. doi: 10.1016/j.brainres.2026.150549.
PubMed
Abstract available
Dynamic contributions of astrocytes in Alzheimer's disease.
Exp Neurol. 2026 Sep 17:116032. doi: 10.1016/j.expneurol.2026.116032.
PubMed
Abstract available
Elevated ferritin expression in microglia and extracellular amyloid-beta deposition
are associated with reduced neurofibrillary degeneration in human isocortex, but
not allocortex.
J Alzheimers Dis. 2026;113:734-746.
PubMed
Abstract available
MRI-free amyloid PET quantification using a deep learning model and white matter
reference.
J Alzheimers Dis. 2026;113:650-660.
PubMed
Abstract available
Do anti-amyloid therapies demonstrate clinically meaningful benefit? A Bayesian
reappraisal.
J Alzheimers Dis. 2026;113:593-597.
PubMed
Abstract available
Hearing in noise and cognitive status in older adults: Biomarker associations and
bidirectional survival analyses.
J Alzheimers Dis. 2026;113:769-780.
PubMed
Abstract available
Predicting future brain atrophy based on longitudinal MRI.
J Alzheimers Dis. 2026;113:796-812.
PubMed
Abstract available
Evaluation of the Addenbrooke's Cognitive Examination-Revised in a routine
cognitive outpatient clinic.
J Alzheimers Dis. 2026;113:822-834.
PubMed
Abstract available
Concordance between plasma biomarkers of phosphorylated tau and tau-PET: A
narrative review.
J Alzheimers Dis. 2026;113:561-577.
PubMed
Abstract available
Cerebral perfusion correlates of domain-specific cognitive function in
Alzheimer's disease and dementia with Lewy bodies.
J Alzheimers Dis. 2026 Sep 14:13872877261482134. doi: 10.1177/13872877261482134.
PubMed
Abstract available
Altered neurovascular coupling in mild cognitive impairment and Alzheimer's
disease: Associations with polysomnography-derived sleep parameters and
cognition.
J Alzheimers Dis. 2026 Sep 15:13872877261487585. doi: 10.1177/13872877261487585.
PubMed
Abstract available
Associations of plasma lipid burden with cognitive performance and decline across
dementia with Lewy bodies, Alzheimer's disease, and Parkinson's disease dementia.
J Alzheimers Dis. 2026 Sep 15:13872877261487127. doi: 10.1177/13872877261487127.
PubMed
Abstract available
A parsimonious three-gene mitochondrial classifier from frontal cortex for
Alzheimer's disease: Nested cross-validation and multicenter external validation.
J Alzheimers Dis. 2026 Sep 15:13872877261487424. doi: 10.1177/13872877261487424.
PubMed
Abstract available
Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study
in usual practice conditions.
J Alzheimers Dis. 2026 Sep 16:13872877261487171. doi: 10.1177/13872877261487171.
PubMed
Abstract available
Periodontal disease and Alzheimer's disease: A systematic review.
J Alzheimers Dis. 2026 Sep 17:13872877261488806. doi: 10.1177/13872877261488806.
PubMed
Abstract available
New mouse models for Down syndrome Alzheimer's disease.
J Alzheimers Dis. 2026 Sep 17:13872877261488873. doi: 10.1177/13872877261488873.
PubMed
Abstract available
Traumatic brain injury and Alzheimer's disease: The null hypothesis wins.
J Alzheimers Dis. 2026 Sep 17:13872877261489299. doi: 10.1177/13872877261489299.
PubMed
Abstract available
The dynamic connectome in Alzheimer's disease: From static snapshots to a
symphony in time-A hypothesis.
J Alzheimers Dis. 2026 Sep 18:13872877261488872. doi: 10.1177/13872877261488872.
PubMed
Abstract available
Multi-omics integration of transcriptomics and metabolomics with machine learning
uncovers novel risk factors for Alzheimer's disease.
J Alzheimers Dis. 2026 Sep 18:13872877261487621. doi: 10.1177/13872877261487621.
PubMed
Abstract available
Utility of biomarkers in prediction of future cognition in Alzheimer's disease
continuum changes over time.
J Alzheimers Dis. 2026 Sep 18:13872877261487572. doi: 10.1177/13872877261487572.
PubMed
Abstract available
Association between caregiving status and cognitive function as well as
activities of daily living among community-dwelling older adults with Alzheimer's
disease: A cross-sectional study.
J Alzheimers Dis. 2026 Sep 18:13872877261488017. doi: 10.1177/13872877261488017.
PubMed
Abstract available
Hospital Artificial Intelligence Tools and Inpatient Utilization and Costs in
Older Adults with Alzheimer's Disease and Related Dementias.
J Am Geriatr Soc. 2026 Sep 14. doi: 10.1111/jgs.70704.
PubMed
Abstract available
Social Media Claims About Blood Tests for Alzheimer's Disease and Dementia: A
Cross-Sectional Content Analysis.
J Am Geriatr Soc. 2026 Sep 15. doi: 10.1111/jgs.70692.
PubMed
Rethinking gamma-Secretase Dysfunction in Alzheimer's Disease: From APP Processing to
Network Perturbation.
J Neurochem. 2026;170:e70550.
PubMed
Behavioural and psychological symptom determinants of carer burden across
clinical syndromes associated with frontotemporal lobar degeneration and
Alzheimer's disease: a transdiagnostic analysis.
J Neurol. 2026;273:592.
PubMed
Abstract available
Diagnostic accuracy of a two-cut-off approach using the FAQ/MMSE ratio and FAQ
for clinical preselection of patients for anti-amyloid therapy.
J Neurol Neurosurg Psychiatry. 2026;97:869-872.
PubMed
Abstract available
FDA Approves 2 New Alzheimer Disease Blood Tests.
JAMA. 2026 Sep 18. doi: 10.1001/jama.2026.14721.
PubMed
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive
Impairment.
JAMA. 2026;336:950-959.
PubMed
Abstract available
Histological aging signatures for monitoring tissue-specific aging and disease.
Nat Med. 2026;32:3466-3476.
PubMed
Abstract available
Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.
Nat Rev Neurol. 2026 Sep 18. doi: 10.1038/s41582-026-01267.
PubMed
Abstract available
Inflection points and transitions in Alzheimer's disease.
Nature. 2026 Sep 16. doi: 10.1038/s41586-026-11110.
PubMed
Abstract available
Map of brain 'microproteins' could offer new clues to Alzheimer's disease.
Nature. 2026 Sep 16. doi: 10.1038/d41586-026-02914.
PubMed
Cognitive resilience helps to predict Alzheimer's dementia.
Nature. 2026 Sep 18. doi: 10.1038/d41586-026-02897.
PubMed
Uncovering heterogeneous effects via localized feature selection.
Proc Natl Acad Sci U S A. 2026;123:e2527033123.
PubMed
Abstract available
Thank you for your interest in scientific medicine.